parkinson's disease سال:2012 - دوره:

Fa | Ar | En


parkinson's disease
سال:2012 - دوره: - شماره:0

17 α -ethynyl-androst-5-ene-3 β,7 β,17 β -triol (HE3286) is neuroprotective and reduces motor impairment and neuroinflammation in a murine MPTP model of Parkinson's disease A 2A receptor antagonism and dyskinesia in parkinson's disease A link between autophagy and the pathophysiology of LRRK2 in Parkinson's disease A manipulation of visual feedback during gait training in Parkinson's disease A novel,sensitive assay for behavioral defects in Parkinsons disease model drosophila A possible novel anti-inflammatory mechanism for the pharmacological prolyl hydroxylase inhibitor 3,4-dihydroxybenzoate: Implications for use as a therapeutic for Parkinson's disease A review of dual-task walking deficits in people with Parkinson's disease: Motor and cognitive contributions,mechanisms,and clinical implications Accuracy of fall prediction in parkinson disease: Six-month and 12-month prospective analyses Adenosine A 2A receptor antagonists do not disrupt rodent prepulse inhibition: An improved side effect profile in the treatment of parkinson's disease Altered dynamic postural control during step turning in persons with early-stage Parkinson's disease An NR2B-dependent decrease in the expression of trkB receptors precedes the disappearance of dopaminergic cells in substantia nigra in a rat model of presymptomatic parkinson's disease Animal models of parkinsons disease 2012 Are verbal fluency and nonliteral language comprehension deficits related to depressive symptoms in Parkinson's disease? Bright light therapy in parkinson's disease: An overview of the background and evidence Clinical aspects and management of levodopa-induced dyskinesia Clinical features,pathophysiology,and treatment of levodopa-induced dyskinesias in Parkinson's disease Cognitive rehabilitation for executive dysfunction in Parkinson's disease: Application and current directions Community walking in people with parkinson's disease Comparing the Mini-BESTest with the Berg Balance Scale to evaluate balance disorders in Parkinson's disease Confirmatory factor analysis of the motor unified Parkinson's disease rating scale Corticostriatal plastic changes in experimental L-DOPA-induced dyskinesia Dementia in Parkinson's disease correlates with α-synuclein pathology but not with cortical astrogliosis Dopamine agonists and pathologic behaviors Dopamine oxidation and autophagy Dyskinesia in Parkinson's disease therapy Dyskinesias and treatment with pramipexole in patients with Parkinson's disease Effect of deep brain stimulation on speech performance in Parkinson's disease Effectiveness of an inpatient movement disorders program for patients with atypical parkinsonism Erratum: Cognitive rehabilitation for executive dysfunction in parkinson's disease: Application and current directions (Parkinson's Disease) Exercise and motor training in people with parkinson's disease: A systematic review of participant characteristics,intervention delivery,retention rates,adherence,and adverse events in clinical trials Factors influencing quality of life in caregivers of people with Parkinson's disease and implications for clinical guidelines Feasibility,safety,and compliance in a randomized controlled trial of physical therapy for parkinson's disease Frontostriatal cognitive staging in Parkinson's disease Gait difficulty,postural instability,and muscle weakness are associated with fear of falling in people with Parkinson's disease Gene therapy for Parkinson's disease Genetic rat models of Parkinson's disease Imbalanced dopaminergic transmission mediated by serotonergic neurons in L-DOPA-induced dyskinesia Impact of anxiety on quality of life in parkinson's disease Impaired economy of gait and decreased six-minute walk distance in Parkinson's disease Importance of the brain angiotensin system in Parkinson's disease Improved dynamic postural task performance without improvements in postural responses: The blessing and the curse of dopamine replacement Improving community healthcare for patients with Parkinson's disease: The dutch model Inflammatory pathways in Parkinsons disease; A BNE microarray study Intensive rehabilitation treatment in parkinsonian patients with dyskinesias: A preliminary study with 6-month followup Is freezing of gait in Parkinson's disease a result of multiple gait impairments? Implications for treatment L-DOPA uptake in astrocytic endfeet enwrapping blood vessels in rat brain LSVT LOUD and LSVT BIG: Behavioral treatment programs for speech and body movement in Parkinson disease Lack of short-term effectiveness of rotating treadmill training on turning in people with mild-to-moderate parkinson's disease and healthy older adults: A randomized,controlled study Magnolol protects against MPTP/MPP + -induced toxicity via inhibition of oxidative stress in in vivo and in vitro models of Parkinson's disease Metacognitive performance,the tip-of-tongue experience,is not disrupted in Parkinsonian patients Mitochondrial dynamics and mitophagy in the 6-Hydroxydopamine preclinical model of Parkinson's disease N-acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells Neurocognitive correlates of apathy and anxiety in parkinson's disease Neuroinflammation in Parkinson's disease and related disorders: A lesson from genetically manipulated mouse models of α-synucleinopathies Neuropsychiatric symptoms in parkinsons disease with mild cognitive impairment and dementia Neuropsychiatry of Parkinson's disease Nonmotor symptoms in Parkinsons disease in 2012: Relevant clinical aspects Parkinson's disease and autophagy Parkinson's disease and mesenchymal stem cells: Potential for cell-based therapy Parkinson's disease and sleep/wake disturbances Parkinsons disease: Leucine-rich repeat kinase 2 and autophagy,intimate enemies Patterns of cell activity in the subthalamic region associated with the neuroprotective action of near-infrared light treatment in MPTP-treated mice Periodontal health and caries prevalence evaluation in patients affected by Parkinson's disease Postmortem interval influences α-synuclein expression in Parkinson disease brain Posture and locomotion coupling: A target for rehabilitation interventions in persons with Parkinson's disease Progressive resistance exercise and Parkinson's disease: A review of potential mechanisms Psychosis assessment in early-stage Parkinson's disease: Comparing Parkinson's psychosis questionnaire with the brief psychiatric rating scale in a Portuguese sample Rehabilitation and Parkinsons disease Reliability in one-repetition maximum performance in people with Parkinson's disease Risk of falls in Parkinson's disease: A cross-sectional study of 160 patients Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease Should one measure balance or gait to best predict falls among people with Parkinson disease? The PIT: SToPP trial- A feasibility randomised controlled trial of home-based physiotherapy for people with Parkinson's disease using video-based measures to preserve assessor blinding The anticholinesterase phenserine and its enantiomer posiphen as 5′untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression The effects of instructions on dual-task walking and cognitive task performance in people with parkinson's disease The emerging role of proteolysis in mitochondrial quality control and the etiology of Parkinson's disease The neuroprotective disease-modifying potential of psychotropics in parkinson's disease The prevalence of fatigue following deep brain stimulation surgery in Parkinson's disease and association with quality of life The protective effect of minocycline in a paraquat-induced Parkinsons disease model in drosophila is modified in altered genetic backgrounds Understanding and prevention of therapy- induced dyskinesias Upper extremity motor learning among individuals with Parkinson's disease: A meta-analysis evaluating movement time in simple tasks Walking ability is a major contributor to fear of falling in people with Parkinson's disease: Implications for rehabilitation Web-based assessment of visual and visuospatial symptoms in Parkinsons disease α-Synuclein and mitochondrial dysfunction: A pathogenic partnership in parkinson's disease?